Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 33: 2292-2295, 1987;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keelan, J. A.
Right arrow Articles by Barling, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keelan, J. A.
Right arrow Articles by Barling, P. M.

Clinical Chemistry, Vol 33, 2292-2295, Copyright © 1987 by American Association for Clinical Chemistry

An alternative fluorescence enhancement solution for use in lanthanide- based time-resolved fluoroimmunoassays

JA Keelan, JT France and PM Barling
Department of Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand.

Time-resolved fluoroimmunoassays that make use of lanthanide chelates as labels require the addition of an enhancement solution to elicit the formation of a fluorescent lanthanide complex. All solutions previously described are based on 2-naphthoyltrifluoroacetone (NTA), a beta- diketone. Currently, this compound is not commercially available. We report here the properties and performance of an enhancement solution prepared with a commercially available beta-diketone, thenoyltrifluoroacetone. Use of this solution in a commercial time- resolved fluoroimmunoassay gave results essentially identical to those obtained with the NTA-based solution, although fluorescence emission was approximately 27% lower. The lower fluorescence yield did not, however, significantly reduce assay sensitivity. We conclude that this solution represents a viable and highly economical alternative to the preparation currently in use, particularly for laboratories wishing to develop their own assays based on lanthanide fluorescence.


The following articles in journals at HighWire Press have cited this article:


Home page
 LupusHome page
A Guth, T Detanico, D Smith, K. Tung, C Bonorino, and L. Wysocki
Spontaneous autoimmunity in mice that carry an IghV partial transgene: a required arginine in VHCDR3
Lupus, April 1, 2009; 18(4): 299 - 308.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Association for Clinical Chemistry.